Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BFLYNYSE:BVSNASDAQ:KRMDNASDAQ:RXST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBFLYButterfly Network$2.30-0.4%$2.39$0.82▼$4.98$568.77M2.592.91 million shs2.31 million shsBVSBioventus$6.54+2.5%$8.17$5.28▼$14.38$535.91M0.95454,664 shs785,274 shsKRMDKORU Medical Systems$3.06+1.7%$2.64$1.86▼$5.05$141.19M0.39139,289 shs245,679 shsRXSTRxSight$13.31+0.5%$18.31$12.53▼$64.50$538.03M1.32670,390 shs1.24 million shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBFLYButterfly Network-3.36%+5.84%-9.09%-50.48%+134.93%BVSBioventus-2.45%-2.60%-19.44%-38.77%+6.51%KRMDKORU Medical Systems-6.23%+10.66%+22.36%-36.63%+30.30%RXSTRxSight+0.30%-11.30%-8.18%-58.46%-78.01%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBFLYButterfly Network2.7911 of 5 stars3.53.00.00.02.52.50.6BVSBioventus3.2866 of 5 stars3.30.00.00.02.84.21.3KRMDKORU Medical Systems2.9081 of 5 stars3.53.00.00.02.92.50.6RXSTRxSight2.8641 of 5 stars4.11.00.00.02.92.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBFLYButterfly Network 3.00Buy$4.0073.91% UpsideBVSBioventus 2.67Moderate Buy$14.33119.16% UpsideKRMDKORU Medical Systems 3.00Buy$4.5047.06% UpsideRXSTRxSight 2.20Hold$37.60182.49% UpsideCurrent Analyst Ratings BreakdownLatest KRMD, BFLY, RXST, and BVS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/8/2025KRMDKORU Medical SystemsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$4.50 ➝ $3.505/7/2025BVSBioventusCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetBuy ➝ Buy$15.005/5/2025BFLYButterfly NetworkLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$5.00 ➝ $4.004/15/2025RXSTRxSightPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageNeutral$18.004/9/2025RXSTRxSightUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$45.00 ➝ $16.004/4/2025RXSTRxSightJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Underweight$40.00 ➝ $17.004/3/2025RXSTRxSightWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$35.00 ➝ $22.004/3/2025RXSTRxSightBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Underperform$36.00 ➝ $22.004/3/2025RXSTRxSightNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$43.00 ➝ $43.003/21/2025RXSTRxSightBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$60.00 ➝ $36.003/19/2025RXSTRxSightStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$33.00 ➝ $28.00(Data available from 5/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBFLYButterfly Network$85.63M6.64N/AN/A$1.06 per share2.17BVSBioventus$567.70M0.94$0.52 per share12.58$2.80 per share2.34KRMDKORU Medical Systems$35.08M4.02N/AN/A$0.45 per share6.80RXSTRxSight$148.31M3.65N/AN/A$4.47 per share2.98Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBFLYButterfly Network-$133.70M-$0.29N/AN/AN/A-129.25%-42.68%-30.31%N/ABVSBioventus-$156.23M-$0.48N/A14.22N/A-7.11%15.61%4.01%N/AKRMDKORU Medical Systems-$13.74M-$0.11N/AN/AN/A-37.42%-24.60%-16.87%N/ARXSTRxSight-$48.61M-$0.67N/AN/AN/A-23.92%-14.00%-12.51%N/ALatest KRMD, BFLY, RXST, and BVS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/7/2025Q1 2025KRMDKORU Medical Systems-$0.02-$0.03-$0.01-$0.03$8.86 million$9.64 million5/7/2025Q1 2025RXSTRxSight-$0.03-$0.03N/A-$0.20$38.74 million$37.90 million5/2/2025Q1 2025BFLYButterfly Network-$0.09-$0.06+$0.03-$0.06$21.16 million$21.23 million2/25/2025Q4 2024RXSTRxSight$0.10-$0.15-$0.25-$0.15$40.23 million$40.21 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBFLYButterfly NetworkN/AN/AN/AN/AN/ABVSBioventusN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/ARXSTRxSightN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBFLYButterfly NetworkN/A4.662.95BVSBioventus1.851.410.99KRMDKORU Medical Systems0.012.992.37RXSTRxSightN/A12.6711.71Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBFLYButterfly Network37.85%BVSBioventus62.94%KRMDKORU Medical Systems58.60%RXSTRxSight78.78%Insider OwnershipCompanyInsider OwnershipBFLYButterfly Network25.18%BVSBioventus32.90%KRMDKORU Medical Systems20.60%RXSTRxSight9.36%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBFLYButterfly Network460247.29 million154.94 millionOptionableBVSBioventus1,20081.94 million54.46 millionNot OptionableKRMDKORU Medical Systems8046.14 million34.10 millionOptionableRXSTRxSight22040.64 million36.53 millionOptionableKRMD, BFLY, RXST, and BVS HeadlinesRecent News About These CompaniesBank of America Corp DE Acquires 413,737 Shares of RxSight, Inc. (NASDAQ:RXST)May 15 at 4:02 AM | marketbeat.comBNP Paribas Financial Markets Makes New Investment in RxSight, Inc. (NASDAQ:RXST)May 15 at 3:55 AM | marketbeat.comVoya Investment Management LLC Sells 70,274 Shares of RxSight, Inc. (NASDAQ:RXST)May 12 at 3:44 AM | marketbeat.comDimensional Fund Advisors LP Acquires 237,877 Shares of RxSight, Inc. (NASDAQ:RXST)May 12 at 3:26 AM | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Just Reported Earnings, And Analysts Cut Their Target PriceMay 10, 2025 | finance.yahoo.comCubist Systematic Strategies LLC Buys 151,358 Shares of RxSight, Inc. (NASDAQ:RXST)May 10, 2025 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Purchased by Algert Global LLCMay 10, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Reaches New 52-Week Low After Earnings MissMay 10, 2025 | americanbankingnews.comEarnings call transcript: RxSight reports Q1 2025 earnings beat, stock rises 6.67%May 9, 2025 | investing.comRxSight, Inc. Reports 28% Revenue Growth in Q1 2025, Highlights Strong Demand for Light Adjustable LensesMay 9, 2025 | nasdaq.comTop 3 Health Care Stocks That Are Preparing To Pump This QuarterMay 9, 2025 | benzinga.comRxSight, Inc. (NASDAQ:RXST) Shares Sold by First Trust Advisors LPMay 9, 2025 | marketbeat.comRxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ...May 8, 2025 | finance.yahoo.comRxSight, Inc. Reports Strong Q1 2025 Revenue GrowthMay 8, 2025 | tipranks.comRxSight, Inc. (RXST) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comRxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue EstimatesMay 7, 2025 | zacks.comRxSight, Inc. Reports First Quarter 2025 Financial ResultsMay 7, 2025 | finance.yahoo.comRxSight (NASDAQ:RXST) Trading Down 6.1% - Here's What HappenedMay 7, 2025 | marketbeat.comRxSight’s Earnings Call: Growth Amid ChallengesMay 6, 2025 | tipranks.comTudor Investment Corp ET AL Purchases 36,669 Shares of RxSight, Inc. (NASDAQ:RXST)May 6, 2025 | marketbeat.comRxSight (RXST) Projected to Post Earnings on WednesdayMay 5, 2025 | americanbankingnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKRMD, BFLY, RXST, and BVS Company DescriptionsButterfly Network NYSE:BFLY$2.30 -0.01 (-0.43%) As of 03:53 PM EasternButterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.Bioventus NYSE:BVS$6.54 +0.16 (+2.51%) As of 04:00 PM EasternBioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis and Stimrouter to treat chronic peripheral pain. Its surgical solutions comprise bone graft substitutes that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries; and ultrasonic products used for precise bone cutting and sculpting, soft tissue management, and tissue debridement, in various surgeries, including minimally invasive applications. The company's product include, Osteoamp, an allograft-derived bone graft for bone grafting procedures; Exponent matrix for posterolateral spine procedures; Purebone for bone grafting procedures; Signafuse bone graft; Interfuse bone graft; Osteomatrix+ synthetic bone graft; Extractor for autologous cell and bone marrow extraction; reficio bone matrix; nexus ultrasonic surgical system; bonescalpel surgical solution; SonaStar for surgical procedures; and SonicOne ultrasonic cleansing and debridement system. The company's restorative therapies include a bone stimulation system and devices to help patients regain leg or hand function due to stroke, multiple sclerosis, or other central nervous system disorders. Its products include exogen, a bone healing system; L300 GO, a foot drop system; H200 rehabilitation system; Vector, a body weight support system; and Bioness integrated therapy system. It developing Talisman pulse generator and receiver for peripheral nerve stimulation. The company was founded in 2011 and is headquartered in Durham, North Carolina.KORU Medical Systems NASDAQ:KRMD$3.06 +0.05 (+1.66%) As of 04:00 PM EasternKORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.RxSight NASDAQ:RXST$13.31 +0.07 (+0.53%) As of 04:00 PM EasternRxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas An Acquisition Just Made Dick's the Most Exciting Stock in Retail Walmart Stock Alert: Big Price Move Expected Soon Broadcom Set to Surge as AI Diffusion Rule Ends Microsoft and OpenAI Just Hit Reset—Here’s Why MSFT Stock Wins Is Bally’s Turnaround a Safe Bet Amid Mixed Investor Sentiment? SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start Intel Makes a Cool Move With Shell, But Will Investors Warm Up? AMD’s AI-Powered Stock Price Rally Just Shifted Gears Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
